Home environmental fungal exposure in patients with Hypersensitivity Pneumonitis
<bold>Introduction:</bold> Mold exposure can be a significant factor in the immunopathogenesis of patients with Hypersensitivity Pneumonitis (HP), thus evaluating exposure in the home environment could offer valuable insights into the mechanisms underlying the disease. <bold>Aims:</bold> To evaluate the mycological exposure in the home environment of patients with HP. <bold>Methods:</bold> A thorough home environment evaluation of patients with a HP diagnosis was performed, including collection of air samples using a single-stage microbiologic air impactor. Upon incubation, fungal colony quantification and microscopic identification were performed. <bold>Results:</bold> Thiry-five patients were included, median age 71 years (32-83), 19 (54.3%) were male. Most patients had fibrotic HP (n=27; 77.1%). A total of 75% of the patients exhibited exposure to potentially hazardous levels of fungus. The air samples revealed 17 distinct fungal species, with Cladosporium and Penicillium spp being the most predominant. While 37.4% of patients self-reported signs of fungal exposure, the investigator's visual assessment identified such indicators in 65.7%. All patients who experienced a significant decline in DLCO or FVC had a history of hazardous fungal exposure. Furthermore, elevated indoor exposure to Aureobasidium pullulans was associated with a decline in FVC over an 18-month follow-up period (72.7 vs 31.6%, p = 0.029). Additionally, a higher concentration of Penicillium spp indoors showed a tendency to be associated with a decrease in DLCO. <bold>Conclusion:</bold> Patients with HP are exposed to high levels of fungal antigens. A professional home environmental evaluation is superior to standard outpatient clinic questionnaire in identifying patients’ exposure.
Authors
- Conceição Souto Moura (ORCID: https://orcid.org/0000-0002-7763-6272)
- Catarina Cardoso (ORCID: https://orcid.org/0000-0002-5483-9317)
- André Carvalho (ORCID: https://orcid.org/0000-0003-2694-0909)
- Natália Melo (ORCID: https://orcid.org/0000-0001-8815-0369)
- Patrícia Caetano Mota (ORCID: https://orcid.org/0000-0002-8157-1125)
- António Morais (ORCID: https://orcid.org/0000-0001-8348-8651)
- João Cavaleiro Rufo (ORCID: https://orcid.org/0000-0003-1175-242X)
- André Terras Alexandre
- Hélder Novais Bastos (ORCID: https://orcid.org/0000-0002-1412-4202)
- Rita Santos (ORCID: https://orcid.org/0000-0002-9048-8075)
- David Jorge Araújo Barros Coelho
- Susana Guimarães (ORCID: https://orcid.org/0000-0002-8628-5195)
Institutions
- Universidade do Porto (PT)
- Hospital de São João (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT)
Publication Details
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa1581
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00